… The ACC/AHA Task Force on Clinical Practice Guidelines has commissioned this
guideline to consolidate existing recommendations and various recent scientific statements …

… This guideline continues the ACC and AHA effort to design a comprehensive yet succinct
compilation of practical guidance for the primary prevention of ASCVD and to promote optimal …

Objective: The objective was to develop clinical practice guidelines for the primary prevention
of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) in patients at …

… needs to be critically appraised and appropriate guidelines developed for their … practice
guidelines for a selected subset of these emerging risk factors as applied in a primary prevention …

… Thus Clinical Practice Guidelines (CPGs) need to carefully consider older … to guide clinicians.
We reviewed CPG recommendations for primary cardiovascular disease (CVD) prevention …

… For primary prevention in patients with moderate risk for a coronary event, we recommend
aspirin, 75–100 mg/d, over either no antithrombotic therapy or vitamin K antagonist (Grade 1A)…

… studies that are testing primary prevention ideas across the spectrum of … primary prevention
practice, the specific and reproducible methods by which practitioners have sought to prevent …

… For primary prevention of cardiovascular disease, we suggest low-dose aspirin (75-100
mg/d) in patients aged > 50 years over no aspirin therapy (Grade 2B). For patients with …

Objective To develop clinical practice guidelines for the primary prevention of atherosclerotic
cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at …

… /AHA practice guidelines. Evaluation of interventions for primary stroke prevention in persons
… , and no primary prevention trials have yet been conducted in patients with this condition. …